Daisy Ridley opens up about graves' disease diagnosis and recovery
Daisy Ridley, best known for her role in "Star Wars: The Rise of Skywalker," shared in an interview with "Women’s Health" that she was diagnosed with Graves' disease last year.
6:11 PM EDT, August 7, 2024
The star admitted that she initially attributed her symptoms to stress related to working on the film "Magpie," a psychological thriller directed by Sam Yates, where she starred alongside actors like Shazad Latif and Matilda Lutz.
Concerning symptoms
The symptoms that worried Ridley included a rapid heartbeat, weight loss, and fatigue. As she recounted, the doctor described her condition as "tired but strange." The diagnosis prompted Ridley to make changes to her diet, including switching to gluten-free products, which, as she notes, positively impacted her well-being. The actress also emphasizes how important it is to listen to your body and be health-conscious, especially considering statistics pointing to the underdiagnosis problem in women.
Ridley joins the ranks of well-known individuals such as Wendy Williams and Missy Elliott, who also struggled with Graves' disease. In her conversation with "Women’s Health," the actress stresses that ignoring symptoms and "normalizing" poor well-being does not lead to anything good. Ridley hopes that her experience will help others pay attention to their health and not ignore the signals sent by their bodies.
Daisy Ridley: Career
Daisy Ridley is a British actress who gained worldwide fame thanks to her role as Rey in the new "Star Wars" trilogy. Initially, fans of the saga were not convinced that a woman was the main character, but they quickly changed their minds, and Ridley became a favorite of many viewers. She has also appeared in films such as "Murder on the Orient Express" and "Ophelia." Unfortunately, not all of her projects were successful. "Chaos Walking," in which she teamed up with Tom Holland, was an artistic and financial flop. Ridley's latest film, "The Girl and the Sea," is available on Disney+.